2,2'-azobis(2-amidinopropane) has been researched along with Leukemia in 1 studies
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zambonin, L | 1 |
| Caliceti, C | 1 |
| Vieceli Dalla Sega, F | 1 |
| Fiorentini, D | 1 |
| Hrelia, S | 1 |
| Landi, L | 1 |
| Prata, C | 1 |
1 other study available for 2,2'-azobis(2-amidinopropane) and Leukemia
| Article | Year |
|---|---|
Dietary phenolic acids act as effective antioxidants in membrane models and in cultured cells, exhibiting proapoptotic effects in leukaemia cells.
Topics: Amidines; Antioxidants; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ce | 2012 |